Biosafety Testing
Cell Therapy
Testing
Minaris Advanced Testing provides rapid mycoplasma detection using the BIOFIRE® Mycoplasma PCR system. Unlike traditional culture-based methods that can take up to 28 days, this automated, closed system delivers results in just 3 days to support accelerated product release.
The platform offers high sensitivity, reduces contamination risk with minimal operator intervention, and aligns with global regulatory expectations (USP, EP, JP).
Common applications include autologous cell therapy release, raw material testing, in-process testing, and rapid investigation of suspected contamination—helping advanced therapy developers ensure patient safety while meeting tight manufacturing timelines.
